Non-Viral Nucleic Acid Delivery System for RNA Therapeutics

被引:4
|
作者
Liu, Lianxiao [1 ]
Zhou, Yiming [1 ]
Xu, Anqiu [1 ]
Wang, Chenglong [1 ]
Li, Ning [1 ]
Huang, Hongwei [1 ,2 ,3 ]
Zhang, Yuntao [4 ]
Yang, Xiaoming [4 ]
机构
[1] China Natl Biol Grp Virogin Biotech Shanghai Ltd, CNBG Virogin, Shanghai 201802, Peoples R China
[2] Virogin Biotech Shanghai Ltd, Shanghai 201802, Peoples R China
[3] Virogin Biotech Canada Ltd, Richmond, ON V6V1A8, Canada
[4] China Natl Biotech Grp CNBG, Beijing 100024, Peoples R China
关键词
drug delivery; gene therapy; nanotechnology; nucleic acid; vectors; RNA therapeutics; NEGATIVE BREAST-CANCER; LIPID NANOPARTICLES; DRUG-DELIVERY; MESSENGER-RNA; GENE DELIVERY; IN-VIVO; MEDIATED DELIVERY; SIRNA DELIVERY; ASIALOGLYCOPROTEIN RECEPTOR; TARGETED DELIVERY;
D O I
10.1002/adtp.202300005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nucleic acid drugs can treat diseases caused by defective or abnormal genes. Herein, the mechanism of non-viral vectors for nucleic acid drug delivery is described. This review introduce non-viral vectors for nucleic acid drug delivery, including the nucleic acid-carrier conjugate, proteins and peptides-based nanoparticles, polysaccharides, and other biological macromolecules-based nanoparticles consisting of lipid nanoparticles, synthetic polymers-based nanoparticles, inorganic nanoparticles, and organic-inorganic hybrid nanoparticles. Finally, the challenges and prospects of non-viral vectors for nucleic acid drug delivery are discussed.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP
    Lin, Yi
    Wagner, Ernst
    Laechelt, Ulrich
    BIOMATERIALS SCIENCE, 2022, 10 (05) : 1166 - 1192
  • [42] A Triple-Fluorophore-Labeled Nucleic Acid pH Nanosensor to Investigate Non-viral Gene Delivery
    Wilson, David R.
    Routkevitch, Denis
    Rui, Yuan
    Mosenia, Arman
    Wahlin, Karl J.
    Quinones-Hinojosa, Alfredo
    Zack, Donald J.
    Green, Jordan J.
    MOLECULAR THERAPY, 2017, 25 (07) : 1697 - 1709
  • [43] Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery
    Buck, Jonas
    Grossen, Philip
    Cullis, Pieter R.
    Huwyler, Jorg
    Witzigmann, Dominik
    ACS NANO, 2019, 13 (04) : 3754 - 3782
  • [44] Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models
    O'Neill, Martin J.
    Bourre, Ludovic
    Melgar, Silvia
    O'Driscoll, Caitriona M.
    DRUG DISCOVERY TODAY, 2011, 16 (5-6) : 203 - 218
  • [45] Non-viral gene delivery
    Behr, JP
    EUROCANCER 98, 1998, : 255 - 256
  • [46] Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery
    Xu, Zhenhua
    Jin, Jiefu
    Siu, Leo K. S.
    Yao, Hong
    Sze, Johnny
    Sun, Hongzhe
    Kung, Hsiang-fu
    Poon, Wai Sang
    Ng, Samuel S. M.
    Lin, Marie C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 426 (1-2) : 182 - 192
  • [47] Localized, non-viral delivery of nucleic acids: Opportunities, challenges and current strategies
    Germershaus, Oliver
    Nultsch, Kira
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 10 (03) : 159 - 175
  • [48] At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids
    Uludag, Hasan
    Ubeda, Anyeld
    Ansari, Aysha
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2019, 7 (JUN):
  • [49] Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders
    Jony, Md Jobair
    Joshi, Ameya
    Dash, Alekha
    Shukla, Surabhi
    PHARMACEUTICALS, 2025, 18 (01)
  • [50] Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
    Durymanov, Mikhail
    Reineke, Joshua
    FRONTIERS IN PHARMACOLOGY, 2018, 9